These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1530409)

  • 1. [Arterial permeability, objective of thrombolytic therapy].
    Bassand JP; Schiele F; Bernard Y; Anguenot T
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):677-87. PubMed ID: 1530409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolytic treatment in acute myocardial infarction.
    Verstraete M
    Circulation; 1990 Sep; 82(3 Suppl):II96-109. PubMed ID: 2118432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombolytic therapy in acute myocardial infarct].
    Verstraete M
    Recenti Prog Med; 1990 Apr; 81(4):287-98. PubMed ID: 2198644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Elements of choice of thrombolytic agents in myocardial infarction].
    Samama M; Brochet E; Valère PE
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):721-7. PubMed ID: 1530414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of anistreplase on coronary patency in acute myocardial infarction].
    Pacouret G; Charbonnier B
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():25-9. PubMed ID: 2108643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of clinical efficacy of thrombolytic drugs in patients with acute myocardial infarction].
    López-Sendón JL
    Rev Esp Cardiol; 1992; 45 Suppl 2():9-20. PubMed ID: 1475514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombolytic treatment of myocardial infarction. Data on the limitation of infarction size and left ventricular function].
    Barraud P; Marcaggi X; Boueyre M; Schandrin C; Regeard E; Maublant J; Lusson JR; Cassagnes J
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):689-95. PubMed ID: 1530410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombolytic therapy of myocardial infarction: practical management].
    Bonnet JL; Bory M
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):707-12. PubMed ID: 1530412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Verh K Acad Geneeskd Belg; 1989; 51(3):191-228; discussion 229. PubMed ID: 2686261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indirect criteria of coronary reperfusion and permeability in patients with acute myocardial infarction who have received thrombolytic therapy].
    Pereira MA; Albuquerque A; Azevedo JG; Torres S; Gomes L; Campos M; Pimenta A
    Rev Port Cardiol; 1991 Mar; 10(3):229-35. PubMed ID: 1854515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    Parise P; Hauert J; Iorio A; Callegari P; Agnelli G
    J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of reperfusion and coronary reocclusion on the variability of heart rate in patients with acute myocardial infarction].
    Pizzi C; Costa GM; Borghi A; Premuda G; Tondini C; Magri G; Cordioli E; Bugiardini R
    Cardiologia; 1999 Feb; 44(2):181-6. PubMed ID: 10208055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is survival in acute myocardial infarction related to thrombolytic efficacy or the open-artery hypothesis? A controversy to be investigated with GUSTO.
    Bates ER
    Chest; 1992 Apr; 101(4 Suppl):140S-150S. PubMed ID: 1555479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombolysis in acute myocardial infarct].
    Erne P
    Ther Umsch; 1991 Aug; 48(8):527-34. PubMed ID: 1926013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiopathologic basis of the use of thrombolytic agents during the acute phase of myocardial infarction].
    Castaigne A; Duval-Moulin AM; Dubois-Randé JL; Merlet P
    Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():15-20. PubMed ID: 2512883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Which thrombolysis in myocardial infarction?].
    Bassand JP
    Ann Cardiol Angeiol (Paris); 1989 Dec; 38(10):635-43. PubMed ID: 2698117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.